Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatoid Arthritis

2013 ACR/ARHP Annual Meeting: Researchers Explore Role of Pathogens, Quality of Care in Rheumatoid Arthritis

Mary Beth Nierengarten  |  January 1, 2014

Funding by the Rheumatology Research Foundation has furthered studies on the impact of infectious agents and autoantigens, periodontal disease, and disease-modifying antirheumatic drugs on patients with RA

2013 ACR/ARHP Annual Meeting: The Rheumatoid Arthritis Treatment Debate

Mary Beth Nierengarten  |  December 1, 2013

Discussion by rheumatologists on the merits of biologics vs. triple therapy for patients with RA lends insight into therapeutic alternatives

2013 ACR/ARHP Annual Meeting: Rheumatology Year in Review

Mary Beth Nierengarten  |  December 1, 2013

Progress in treatments for pediatric rheumatic diseases, collaborative clinical trials, and personalized therapeutic approaches highlight the past year in rheumatology

Letters: Criticism for Complementary and Alternative Medicine Therapies in Rheumatoid Arthritis

Maarten Boers, MSc, MD, PhD, and Chenchen Wang, MD, MSc  |  December 1, 2013

One reader calls claims about the effectiveness of CAM to treat RA misleading; author notes proving the efficacy of alternative treatments remains challenging

Doest Rheumatoid Arthritis Take a Toll?

By Richard M. Pope, MD  |  November 15, 2013

Exploring the Toll background

What Diet to Recommend to Patients with Rheumatoid Arthritis?

Vanessa Caceres  |  November 1, 2013

With no clear-cut, evidence-based dietary guidelines for RA, rheumatologists should advocate for a balanced diet to help patients reduce their risk of obesity, cardiovascular disease, and osteoporosis

Tips for Rheumatologists to Prevent, Alleviate Back Pain in Patients with Rheumatic Disease

Kimberly Retzlaff  |  November 1, 2013

A multidisciplinary approach that incorporates an exercise program, physical therapy, and ways to maintain good posture and a healthy weight can help patients find relief

Survey Highlights High Out-of-pocket Costs for RA Care

Richard Quinn  |  October 25, 2013

The “RA in America 2013″ survey estimates out-of-pocket cost for RA treatment at  $1,000 to $5,000 per year. (posted Oct. 25)

Study Points to Need for Increased Antirheumatic Therapy in Patients with Dyslipidemia

Lara C. Pullen, PhD  |  October 4, 2013

A new study suggests that patients diagnosed with RA as well as dyslipidemia may benefit from more aggressive antirheumatic therapy.   (posted Oct. 3, 2013)

EULAR 2013: Research Hints at Risk Factors for Rheumatoid Arthritis

Thomas R. Collins  |  September 1, 2013

Studies point to involvement of anti-CCP antibodies and citrullinated targets in the lungs and joints in the development of RA, and suggest an early therapeutic window for prevention

  • « Previous Page
  • 1
  • …
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 75
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences